← Browse by Condition
Medical Condition
systemic sclerosis ssc
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for systemic sclerosis ssc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — systemic sclerosis ssc Clinical Trials
How many clinical trials are currently recruiting for systemic sclerosis ssc?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for systemic sclerosis ssc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for systemic sclerosis ssc?
systemic sclerosis ssc research spans Phase 1 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a systemic sclerosis ssc clinical trial?
Eligibility criteria for systemic sclerosis ssc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07245238 Phase 3
Recruiting
Enrollment
36 pts
Location
Thailand
Sponsor
Khon Kaen University
NCT07413341 Phase 1
Recruiting
Enrollment
12 pts
Location
China
Sponsor
Therorna
NCT07292961
Recruiting
Enrollment
48 pts
Location
Turkey (Türkiye)
Sponsor
Hacettepe University
NCT07104721 Phase 1
Recruiting
Enrollment
18 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
NCT07236970
Recruiting
Enrollment
350 pts
Location
Spain
Sponsor
Alejandro Cruz Utrilla
NCT06865118
Recruiting
Enrollment
20 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT07182981
Recruiting
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Hacettepe University
NCT07249060
Recruiting
Enrollment
300 pts
Location
Spain
Sponsor
Hospital Universitario Araba
Related Conditions
systemic lupus erythematosus sle (2) inflammatory myopathy (2) scleroderma (2) scleroderma localized (2) scleroderma limited and diffuse (2) mediciine (1) intervention study (1) sjogren s syndrome ss (1) anca associated systemic vasculitis (1) scleroderma systemic (1) systemic sclerosis 2013 acr eular classification criteria (1) juvenile systemic sclerosis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology